NAVIGATION
Oncology Strategy Meeting Europe 2017

Proventa International will be gathering over 100 C-Level Directors from a mix of emerging to large Pharmaceutical, Biotechnology & Academic/Research Institutions to help solve their key strategic challenges in the area of Oncology.

Register Now
24th October 2017, Radisson Blu Portman Hotel, London
2017-10-24 07:30:00 2017-10-24 19:00:00 Europe/London Oncology Strategy Meeting Europe 2017 24th October 2017, Radisson Blu Portman Hotel, London Proventa International will be gathering over 100 C-Level Directors from a mix of emerging to large Pharmaceutical, Biotechnology & Academic/Research Institutions to help solve their key strategic challenges in the area of Oncology. http://proventainternational.com/oncology-eu/ Radisson Blu Portman Hotel Ambreen Anwer aa@proventainternational.com

Agenda

The Oncology Roundtable Discussions Strategy Meeting are for qualified end-users. These include Senior Executives of Oncology/Immuno-Oncology (from medium to large Pharma, Biopharma and Biotech players) in global development positions spanning early development to phase IV, as well as thought leaders from Academia and regulatory authorities.

Thought leaders who will benefit from attending include CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for:
– Oncology R&D,Translational Research/Development/Medicine, Clinical Research/Development, Immuno-Oncology, Medical Affairs Oncology,Clinical Pharmacology,Oncology Clinical Biostatistics and Programming, Oncology Clinical Genomics and Computational Biology, Oncology R&D Innovation, Oncology R&D Strategy, Oncology Portfolio/Project Management.

Those who do not qualify for VIP passes, including vendors, exchanges, consultancies and other service providers, can apply here.

Oncology Strategy Meeting Europe 2017

DOWNLOAD AGENDA

Advisory Board

Testimonials

 

Oncology Strategy Meeting Europe 2016 - Return On Investment, Hear what our clients had to say about their experience at the Oncology Strategy Meeting EU 2016

Oncology Strategy Meeting Europe 2016 - Roundtable Discussion Format?,  Hear what our clients had to say about their experience at the Oncology Strategy Meeting EU 2016

Oncology Strategy Meeting Europe 2016 - Level of Delegation, Hear what our clients had to say about their experience at the Oncology Strategy Meeting EU 2016

Oncology Strategy Meeting Europe 2016 - 1-1 Pre qualified Business Meetings, Hear what our clients had to say about their experience at the Oncology Strategy Meeting EU 2016

Samuel T. Labrie, VP Corporate Development, Myriad RBM

Kam Dhaliwal, SVP Services & Alliances, Horizon Discovery

Matt Hersch, Clinical Operations Manager, GW Pharmaceuticals

Rainer Metzger,  VP Global Business Development Pharma, Qiagen

Dilsaid Babayigit, Founder & CEO, Ageneo

John Apathy, Vice President, R&D informatics, Celgene

Lars Branden, Senor Director,Informatics R&D Division, Retro Screen Virology Ltd.

Dominic Clark , Industry Programme Manager, EMBL-EBI

Yike Guo, Director Data Science Institude, Imperial College London

John Wise, Executive Director, Pistoia Alliance

Abel Ureta-Vida, CEO, Eagle Genomics

Alexander Scheer, Deputy Head of Research, Pierre Fabre

Jerome Wojcik , CEO, Quartz Bio

Oleksandr Otava, Head Of Scientific IT, Affiris AG

Sowmyanarayan Srinivasan, Director R&D Practise, Global Delivery Leader Discovery

,

Oncology Strategy Meeting Europe 2016 - Return On Investment, Hear what our clients had to say about their experience at the Oncology Strategy Meeting EU 2016

Oncology Strategy Meeting Europe 2016 - Roundtable Discussion Format?,  Hear what our clients had to say about their experience at the Oncology Strategy Meeting EU 2016

Oncology Strategy Meeting Europe 2016 - Level of Delegation, Hear what our clients had to say about their experience at the Oncology Strategy Meeting EU 2016

Oncology Strategy Meeting Europe 2016 - 1-1 Pre qualified Business Meetings, Hear what our clients had to say about their experience at the Oncology Strategy Meeting EU 2016

Samuel T. Labrie, VP Corporate Development, Myriad RBM

Kam Dhaliwal, SVP Services & Alliances, Horizon Discovery

Matt Hersch, Clinical Operations Manager, GW Pharmaceuticals

Rainer Metzger,  VP Global Business Development Pharma, Qiagen

Dilsaid Babayigit, Founder & CEO, Ageneo

John Apathy, Vice President, R&D informatics, Celgene

Lars Branden, Senor Director,Informatics R&D Division, Retro Screen Virology Ltd.

Dominic Clark , Industry Programme Manager, EMBL-EBI

Yike Guo, Director Data Science Institude, Imperial College London

John Wise, Executive Director, Pistoia Alliance

Abel Ureta-Vida, CEO, Eagle Genomics

Alexander Scheer, Deputy Head of Research, Pierre Fabre

Jerome Wojcik , CEO, Quartz Bio

Oleksandr Otava, Head Of Scientific IT, Affiris AG

Sowmyanarayan Srinivasan, Director R&D Practise, Global Delivery Leader Discovery

Location

Radisson Blu Portman Hotel 22 Portman Square, London W1H 7BG
United Kingdom

Date: Oct 24,2017 Time:7:30AM – 9:00PM

Book your seat for the Oncology Strategy Meeting Europe 2017

DELEGATE REGISTRATION